Publication | Open Access
PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
75
Citations
0
References
2021
Year
Surgical OncologyPs01.05 SurgicalHealth SciencesMedicinePathologyImmune Checkpoint InhibitorClinical OutcomesPharmacotherapyCancer TreatmentOncologyRadiation OncologyNeoadjuvant Atezolizumab
No additional data available for this publication yet. Check back later!